Naloxone treatment in opioid addiction: the risks and benefits.
about
The relative potency of inverse opioid agonists and a neutral opioid antagonist in precipitated withdrawal and antagonism of analgesia and toxicity[Naloxone-induced pulmonary edema. Case report with review of the literature and critical evaluation].Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption.Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.Opiate withdrawal complicated by tetany and cardiac arrestThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological MethodsShort term morphine exposure in vitro alters proliferation and differentiation of neural progenitor cells and promotes apoptosis via mu receptors.New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.Exploring drug-target interaction networks of illicit drugs.The role of opioid antagonist efficacy and constitutive opioid receptor activity in the opioid withdrawal syndrome in miceEffects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxideInvestigating the effects of a hydrolytically stable hapten and a Th1 adjuvant on heroin vaccine performance.Addiction and substance abuse in anesthesiologyBinding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mCombined oral prolonged-release oxycodone and naloxone in chronic pain management.Buprenorphine use in pregnant opioid users: a critical review.Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review.Naloxone prolongs cutaneous nociceptive block by lidocaine in rats.Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation.Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.Harm Reduction: Front Line Public Health.Comparing Symptoms of Withdrawal, Rapid Detoxi-fication and Detoxification with Clonidine in Drug Dependent Patients.Comparison of Quantitative and Qualitative Dermatoglyphic Characteristics of Opium Addicts with Healthy Individuals.Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.Acute Myocardial Infarction following Naltrexone Consumption; a Case Report.Choosing Opioid Policies Our Patients Can Live With.In Response to: "The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty".Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study.Comparison of electroencephalographic changes in response to acute electrical and thermal stimuli with the tail flick and hot plate test in rats administered with opiorphin.Naloxone inhibition of lipopolysaccharide-induced activation of retinal microglia is partly mediated via the p38 mitogen activated protein kinase signalling pathway.Improved Admixture Vaccine of Fentanyl and Heroin Hapten Immunoconjugates: Antinociceptive Evaluation of Fentanyl-Contaminated Heroin
P2860
Q24647249-C681DCDD-F74B-40C9-BDDD-0B561E2F68CEQ33399846-567068F7-863F-46C4-BA16-31FC2DEB2721Q33520508-69C8F5D2-E20E-4564-8192-AC3F9BCA3808Q33747985-A2F05A3F-92A4-48A2-97A7-7443953B10B6Q33815047-2539FD64-315B-4A18-A2A4-75BEEDFAB4A0Q33849829-AD8AD28B-790B-4917-A8B5-039F74A5B185Q33870389-1B43040D-B847-4C05-A975-D4225A7E3E13Q33875227-B27F3C20-6942-464B-B278-B5DB77C1BFD5Q33968232-28ED8785-F488-449F-B6EE-C240DDEC1893Q34952233-D81DAA8B-E24F-4A27-9BCD-EEC6A86B2D69Q35051482-7174FCA7-1FE6-47F0-B7AB-4CC4D9020C16Q35165171-EFC2DA53-2FAA-41E9-933A-4C1B1BBB99BCQ35925351-CE3E9093-ED24-4850-ADDD-C09EFE1D60D5Q36479824-F62C7D48-77E5-473F-AD1D-8B88885D825DQ37306382-28C03B68-2E2E-4279-84C7-7762E98E4804Q37317909-480B37B0-3FD4-4A92-9113-37B505F9E2A3Q38065187-1508B12F-381F-4FE2-8413-BA0EC47F609AQ38115201-48DE1AC3-E9A8-4110-9D31-B6C772613DA1Q38243268-6DBA3A42-0759-4DB2-90E6-7CF2382C4BDBQ38417339-1E2676BB-CECF-4297-B8C7-5244D6A9EC12Q38693513-06E397FD-11FD-4CCC-942A-0D45DD84D5CAQ38743944-CC49362D-C2C0-4ADD-873D-B42F0B89DB01Q38948561-6E57AA53-F027-482B-9506-9FE388B762F3Q41157775-1BAC2AF8-DE0D-4B7A-B283-E55BD513DEDFQ41897675-A4C04891-C12C-487B-945A-7EF022C9CC8EQ42055542-59DBA4E5-7A2C-4021-8C11-54CB7E708348Q42059731-6C0E248F-5474-471A-B147-E8CF3916E072Q42183983-800C5AC4-9296-4085-AB70-1500076A35B1Q44338231-CA63660B-1DA2-438B-AE2B-8CD402BD40BBQ44340962-5C099B10-59BF-4B0E-81A8-6D4CFFC9DCB6Q44349836-5AFA8045-F918-4396-8EDF-C19371B72ADAQ47165482-8D3FF2DE-3E5B-4513-956B-681289133D00Q52577416-03823FB0-0FC3-4D69-A304-FBE5D64098E8Q54484453-92CF7784-E1E6-4309-A1E9-597EA0C12259Q57063495-05D67594-0C0C-4F96-A333-94DECB61CA52
P2860
Naloxone treatment in opioid addiction: the risks and benefits.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Naloxone treatment in opioid addiction: the risks and benefits.
@en
type
label
Naloxone treatment in opioid addiction: the risks and benefits.
@en
prefLabel
Naloxone treatment in opioid addiction: the risks and benefits.
@en
P2093
P2860
P356
P1476
Naloxone treatment in opioid addiction: the risks and benefits.
@en
P2093
Albert Dahan
Ashraf Yassen
Eveline L A van Dorp
P2860
P304
P356
10.1517/14740338.6.2.125
P407
P577
2007-03-01T00:00:00Z